The management of Hepatitis B Minor Triple Positive with slightly high liver function of both direct bilirubin and indirect bilirubin includes antiviral therapy, hepatoprotective therapy, surgical therapy, etc., which need to be combined with the amount of Hepatitis B Virus, aminotransferases, alpha-fetoprotein and other test items. Hepatitis B minor triple positive refers to hepatitis B surface antigen, e antibody and core antibody are positive. If accompanied by elevated bilirubin, hepatoprotective treatment should be given, commonly used drugs include glutathione, silymarin glucosamine and so on. If accompanied by the elevation of hepatitis B virus, antiviral treatment should be given, commonly used drugs include entecavir, tenofovir, and so on. If accompanied by the elevation of transaminase, it is necessary to give enzyme-lowering treatment, commonly used drugs are biphenyldiphenyl ester, compound glycyrrhizic acid tablets and so on. If accompanied by elevated tumor markers such as alpha-fetoprotein, CA199, etc., we need to be alert to hepatocellular carcinoma, pancreatic head cancer and other tumors. Combine with abdominal intensive ct, percutaneous hepatic puncture and other examinations to clarify, and consider whether to treat surgically. For Hepatitis B minor triple yang with elevated direct bilirubin and indirect bilirubin, it is recommended to consult a doctor for clarification of the specific situation and then give treatment.